semaglutide compounding fda Hims & Hers stock falls 25% as curtails compounded GLP-1s compounding semaglutide news FDA alerts

doi:10.1002/jps.22639 Albert BB, Derraik JGB, Brennan CM, et al

In some cases, compounders may be using salt forms of semaglutide, including semaglutide sodium and semaglutide acetate

During the Ozempic and Wegovy shortages of 2023 and 2024, compounding pharmacies began producing their own versions of semaglutide and tirzepatide

Table of Contents How Tesamorelin and Retatrutide Work in the Body Potential Interactions Between These Two Medicines What the Current Evidence Says About Combined Use Risks and Safety Considerations to Discuss With Your Doctor When Combined Metabolic Treatments May Be Considered Seeking Guidance From a UK Specialist or Prescriber Scientific References Frequently Asked Questions How Tesamorelin and Retatrutide Work in the Body Tesamorelin stimulates pituitary GH release to reduce visceral fat via the GH/IGF-1 axis, whilst retatrutide is a tri-agonist targeting GLP-1, GIP, and glucagon receptors to suppress appetite and improve metabolism

This creates a catastrophic hormonal feedback loop: More body fat leads to more aromatase enzyme